Analyst Ratings for Novo Nordisk A/S ADR (NVO)

Updated: 2017-07-28

Analysts covering Novo Nordisk A/S ADR (NYSE:NVO) have given it a consensus rating of Overweight. About 30 days ago, NVO was issued an average rating of Hold.

A buy rating was issued by 12 analysts, 2 gave an overweight rating, 14 gave a hold rating, 3 gave an underweight rating, and 3 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Meanwhile, the number of analysts pessimistic about the company has decreased by 1.

Many analysts weighed in on price targets for NVO. The most optimistic analyst gave a price target of 53.74, implying potential capital gains of 29.53 percent. The most pessimistic price target was 30.94, implying a possible loss of -25.43 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates upwards for this quarter, by about 3.64 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is 4.58 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 1.99 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 5.01 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 2 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. During this time, 3 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of NVO's earnings is estimated by analysts to be 1.32 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of NVO is 13.93.

NVO has a 52-week high of 57.41 and a 52-week low of 30.89. The current market price is above the trailing year's low by 34.32 percent, and 27.73 percent lower than its 52-week high. NVO has a price/earnings ratio of 18.39. Investors typically compare the P/E ratio to a company's peers in the industry. The NVO value stock report compares NVO to some of its peers using value stock charts. The stock has a market capitalization of $104.49 billion. NVO is estimated to release their earnings results for the quarter on 0000-00-00, days from today.